tag:blogger.com,1999:blog-4230162007222918868.post7302801267401545615..comments2023-09-19T05:50:03.130-04:00Comments on Renal Fellow Network: TREAT TrialGearoid McMahonhttp://www.blogger.com/profile/08049723797363526138noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-4230162007222918868.post-38342510978974664092010-01-29T09:56:19.810-05:002010-01-29T09:56:19.810-05:00The TREAT Trial was designed prior to the shift in...The TREAT Trial was designed prior to the shift in treating to a target of 12 on the high end. The ESA labels have always noted a target range of 10-12.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-4230162007222918868.post-35850080032631013072009-11-10T23:00:12.759-05:002009-11-10T23:00:12.759-05:00I don't know why the recent ESA trials keep ta...I don't know why the recent ESA trials keep targeting a HgB of 13 or more. The FDA labeling is 10-12 and that is what the community practice is. Medicare and other carriers will pick up on this and try to restrict ESA use, even in the appropriate target range, if we are not careful. It will ultimately start restricting what may be legitimate and safe use of ESA...Unknownhttps://www.blogger.com/profile/09093876133363526145noreply@blogger.com